Message from the Chairman

Development of New Drugs, Care for Life, Implementation of Governance, Pursuit of Sustainability

Microbio Co., Ltd. espouses the core values of “integrity, innovation, and Love” and embraces the corporate mission of “Developing New Drugs and Caring for Life”. We are steadfastly committed to developing new drugs to satisfy unmet medical needs. We will operate stably under the corporate culture of ” Modesty , Proactiveness, Sincerity, and Innovation”. We have established a healthcare domain that encompasses the four dimensions of new drug development, medical-grade health supplements, investments in biotechnology, and organic products.

The year 2023 is a critical year for Microbio to enter the international market for innovative products. In the first half of the year, we completed the pre-application meeting with the FDA for MB107, a topical medical device for atopic dermatitis and sensitization dermatitis, and the gap analysis of the GRAS certification application for the oral micro-ecological product. In the second half of the year, we completed the 510K submission for the US FDA for MB107, a dermatological medical device, and confirmed that the micro-ecological food for special medical purposes meet the regulatory requirements for applying for US GRAS certification. To prepare for the upcoming launch of our products in the U.S., we also conduct U.S. insurance payment assessments to secure favorable conditions for the Food for Special Medical Purposes (FSMP) and innovative medical device products to enter the international market. The medical and health products are based on the core technology platform and scientific team established by the New Drug Research and Development Institute, adhering to the high-standard R&D and manufacturing of biotechnology pharmaceuticals. Currently, we are also actively planning the e-commerce and cloud sales of core featured products to expand into the international market.

Apart from insisting on R&D and innovation to achieve various operational goals, Microbio complies with the “Sustainable Development Roadmap” and “Sustainable Development Action Plan” released by the FSC and continues to promote ESG through introduction of resources. The ESG implementation is overseen by the Sustainable Development Committee under the Board of Directors. In the 10th Corporate Governance Evaluation published at the end of April 2024, the Company was selected as the highest honor among the “Top 5% of the TPEx listed companies” for three consecutive terms, and was selected as the highest honor for the “non-financial electronics companies with a market value of more than NTD 10 billion” listed on the TWSE for two consecutive terms in the best top 10%. The outstanding result of the corporate governance evaluation is an important recognition for our colleagues’ dedication to corporate governance, environmental sustainability, and promotion of social inclusion. In terms of the environment, the Company complies with regulatory requirements by including subsidiaries in consolidated financial statements in the scope of GHG inventory and verification, and completed the replacement of the old chiller system in the Longtan Plant in the second quarter of 2023. In terms of society, we have long-term cooperation with public welfare organizations to take care of disadvantaged groups and education in remote areas, care for cancer patients, and improve cancer education knowledge. This year, we even encouraged our colleagues to participate in social welfare through volunteer leave. In October 2023, we joined the activities of the Breast Cancer Patient Association with the subsidiary Cotton Field Organic, to support international breast cancer prevention and control and promote organic and healthy living.

Looking into the future, the Company will continue to move toward the vision of “Healthy Lifestyles Sustainable Prosperity for All “, adopting culture and legal governance, R&D through innovation and efficiency, and treating people and the society with good things. We strive to contribute to society with ethical corporate management, technological innovation, and realizing sustainable development to maximize business value and shareholders’ equity.